Allogeneic mesenchymal stem cells may be a viable treatment modality in cerebral palsy

Figure 2 Detection of the differentiation potential of Wharton’s Jelly–derived-mesenchymal stem cells. A and B: Wharton's Jelly Derived-mesenchymal stem cells (WJ-MSCs) were cultured without adipogenic induction and cultured for 3 wk in adipogenic differentiation medium. Adipogenic differentiation was evidenced by the formation of lipid vacuoles with oil red O staining; C and D: WJ-MSCs were cultured without osteogenic induction and cultured for 3 wk in osteogenic differentiation medium. Osteogenic differentiation was evidenced by the detection of calcium deposits with Alizarin red staining; E and F: WJ-MSCs were cultured without chondrogenic induction and cultured for 3 wk in chondrogenic differentiation medium. Chondrogenic differentiation was evidenced with Alcian blue staining.